Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
ISTH 2022
In an interview from #SOHO2025, @drjoannarhodes1 of @RutgersCancer shares insights into the cost-effectiveness of continuous BTK inhibitor therapy in patients with CLL, outlining findings from a Medicare financial analysis.💰
Watch now:
🎥
#CLLsm #Leusm…
Cost-effectiveness of continuous BTK inhibitors in patients with CLL: a Medicare financial analysis
Joanna Rhodes, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, shares insights into the cost-effectiven...
ow.ly
Have you had a chance to explore our exclusive content from #iwHRMM25? 🤔🎥
Watch all the presentations and expert-led discussions from this fantastic event to gain valuable insight into updates & advances in high-risk #myeloma.🩸
Click here: 👉 https://ow.ly/nKJB50Xqqe5
#MMSM…
🎥 @MdSwoboda of @TGHCares discusses the growing use of artificial intelligence in MDS, highlighting ongoing research in this area:
👉 👈
#MDSsm #ArtificialIntelligence #AIinHealthcare #HemOnc #SOHO2025
The growing role of AI in MDS: digital twins, machine learning tools, and more
David Swoboda, MD, Tampa General Hospital Cancer Center, Tampa, FL, discusses the growing use of artificial intelligen...
ow.ly
#iwHRMM25 | Sham Mailankody of @MSKCancerCenter discusses innovative approaches to trial design in high-risk #myeloma, highlighting how these may improve data collection:
🎥
#Myeloma #MMSM #HemOnc #CTSM
Innovative approaches to trial design in high-risk myeloma & how these may improve data collection
Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the challenges of treating high...
ow.ly
🎥 @DrAEvens of @RutgersCancer shares insights into the HoLISTIC Consortium, a global NIH-funded initiative that has aggregated data from over 30,000 patients with #HodgkinLymphoma.
Learn more by clicking here:
👉 👈
#18ICML #LYMsm #Lymphoma #HemOnc
Insights into the HoLISTIC Consortium & the value of this initiative
Andrew Evens, DO, MBA, FACP, Rutgers University, New Brunswick, NJ, shares insights into the HoLISTIC Consortium, a ...
ow.ly
ISTH 2022
In an interview from #SOHO2025, @drjoannarhodes1 of @RutgersCancer shares insights into the cost-effectiveness of continuous BTK inhibitor therapy in patients with CLL, outlining findings from a Medicare financial analysis.💰
Watch now:
🎥
#CLLsm #Leusm…
Cost-effectiveness of continuous BTK inhibitors in patients with CLL: a Medicare financial analysis
Joanna Rhodes, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, shares insights into the cost-effectiven...
ow.ly
Have you had a chance to explore our exclusive content from #iwHRMM25? 🤔🎥
Watch all the presentations and expert-led discussions from this fantastic event to gain valuable insight into updates & advances in high-risk #myeloma.🩸
Click here: 👉 https://ow.ly/nKJB50Xqqe5
#MMSM…
🎥 @MdSwoboda of @TGHCares discusses the growing use of artificial intelligence in MDS, highlighting ongoing research in this area:
👉 👈
#MDSsm #ArtificialIntelligence #AIinHealthcare #HemOnc #SOHO2025
The growing role of AI in MDS: digital twins, machine learning tools, and more
David Swoboda, MD, Tampa General Hospital Cancer Center, Tampa, FL, discusses the growing use of artificial intelligen...
ow.ly
#iwHRMM25 | Sham Mailankody of @MSKCancerCenter discusses innovative approaches to trial design in high-risk #myeloma, highlighting how these may improve data collection:
🎥
#Myeloma #MMSM #HemOnc #CTSM
Innovative approaches to trial design in high-risk myeloma & how these may improve data collection
Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the challenges of treating high...
ow.ly
🎥 @DrAEvens of @RutgersCancer shares insights into the HoLISTIC Consortium, a global NIH-funded initiative that has aggregated data from over 30,000 patients with #HodgkinLymphoma.
Learn more by clicking here:
👉 👈
#18ICML #LYMsm #Lymphoma #HemOnc
Insights into the HoLISTIC Consortium & the value of this initiative
Andrew Evens, DO, MBA, FACP, Rutgers University, New Brunswick, NJ, shares insights into the HoLISTIC Consortium, a ...
ow.ly
